Standard issue transfusion versus fresher red blood cell use in intensive care (TRANSFUSE) study update
14 February 2018 01:30pm - 02:30pm Australia/Sydney
This session will report the results for the TRANSFUSE-RCT, the multi-centre, randomised, controlled trial, testing the effect of the freshest available red blood cell (RBC) unit compared to standard practice, on mortality in critically ill patients who require RBC transfusion.
|Presenter:||Dr Zoe McQuilten, Consultant Haematologist, Senior Research Fellow, Monash University.|
- Improve awareness of the outcomes for the Transfuse study.
- Describe the clinical implications for red blood cell transfusion in ICU following the outcomes of the study.